DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

SVB Leerink Initiates Coverage On Adverum Biotechnologies with Outperform Rating, Announces $17 Price Target

SVB Leerink analyst Mani Foroohar initiates coverage on Adverum Biotechnologies (NASDAQ:ADVM) with a Outperform rating and a $17 price target.

Benzinga · 03/16/2020 10:58

SVB Leerink analyst Mani Foroohar initiates coverage on Adverum Biotechnologies (NASDAQ:ADVM) with a Outperform rating and a $17 price target.